Request Customized Report As Per Your Requirements: https://www.factmr.com/connectus/sample?flag=RM&rep_id=1154
Rapidly growing aging demographics coupled with growing incidence of dementia are the factors driving the growth of Lewy Body Dementia Treatment Market over the forecast period. According to the NHS U.K., over 100,000 people in the U.K are suffering from Lewy body dementia and is one of the common types of dementia. Lewy body dementia accounts for approximately 5Ė15% of all dementia. Number of patients with comorbid conditions such as LBD and Alzheimerís disease, LBD and Parkinsonís disease, Senile dementia with LBD, etc. are growing rapidly, which is expected to drive the growth of Lewy body dementia treatment market over the forecast period. However, there exist no differential diagnostic tests that can differentiate LBD from other similar disorders such as Alzheimerís disease and Parkinsonís disease. This restricts early treatment of Lewy body dementia, which may deter the global market growth.
The global Lewy body dementia treatment market is segmented on the basis of treatment type, distribution channel, and geography:
- Segmentation by Treatment Type
- Sleep Disorder Treatment
- Cognitive Impairment Treatment
- Paradoxical Agitation Treatment
- Motor Function Improvement Treatment
- Segmentation by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Drug Store
Early and aggressive treatment of cognitive symptoms with anticholinergics is recommended to patients with Lewy body dementia. Treating all sleep disorders is necessary for optimal cognitive function. Melatonin and clonazepam are suggested for treatment of REM sleep behavior disorder. Some medications used to treat Alzheimerís disease also may be used to treat the cognitive symptoms of LBD. Recently approved Excelon patch by Novartis AG, can be used to treat cognitive symptoms of LBD. By distribution channels, retail pharmacy segment is expected to lead the global market.
Browse full details about Lewy Body Dementia Treatment Market report: https://www.factmr.com/report/1154/lewy-body-dementia-treatment-market
Examples of some of the key players identified in the global Lewy body dementia treatment market are Sun Pharmaceutical Industries Limited, Apotex Corporation, GlaxoSmithKline Plc., Pfizer Inc., Sanofi SA, Boehringer Ingelheim International GmbH, Mallinckrodt, Takeda Pharmaceutical Company Limited, Sunovion Pharmaceuticals, Inc., and Sandoz (Novartis AG), among others.
Regional analysis includes
- North America
- Latin America
- Asia Pacific
- Middle East & Africa
- Shifting Industry dynamics
- In-depth market segmentation
- Historical, current and projected industry size Recent industry trends
- Key Competition landscape
- Strategies for key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance
Make an inquiry for purchasing this report: https://www.factmr.com/connectus/sample?flag=AE&rep_id=1154
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Rockville, MD 20852
Read Industry News at - https://www.industrynewsanalysis.com/